Clinical Trial Update: Preventing Recurrence of Thromboembolic Events Through Coordinated Treatment in the District of Columbia [Phase 2]

View source ↗

Summary

A Phase 2 Georgetown University clinical trial aimed at preventing recurrence of thromboembolic events in stroke patients in the District of Columbia has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Snippet

Sponsor: Georgetown University | Conditions: Stroke | Phase 2 | Status: COMPLETED